MiNK Therapeutics, Inc. - Common Stock (INKT)
8.4880
+0.5080 (6.37%)
Mink Therapeutics Inc is a biotechnology company focused on developing innovative therapeutic solutions to address unmet medical needs
The company specializes in creating advanced treatments targeting various diseases and conditions by leveraging cutting-edge technologies in drug discovery and development. With a commitment to enhancing patient outcomes, Mink Therapeutics aims to bring novel therapies from the lab to the clinic, fostering improvements in healthcare through scientific research and collaboration.